APA

Maurer M. J., Habermann T. M., . (20191018). Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Maurer M J, Habermann T M, . 20191018. Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Maurer M. J., Habermann T. M., . (20191018). Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Maurer M J, Habermann T M, . Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al. : Annals of oncology : official journal of the European Society for Medical Oncology. 20191018.